Safety of Epidural Fentanyl and Adrenalin During Childbirth

Sponsor
Oslo University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00685672
Collaborator
University Hospital, Akershus (Other)
40
2
2
89
20
0.2

Study Details

Study Description

Brief Summary

Investigation of pharmacokinetic effects of combining fentanyl and adrenalin in the epidural solution given to women in childbirth

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

Healthy women with indication for labor epidural at the Labor Clinic, Rikshospitalet University Hospital, may be included. A randomized, placebocontrolled, double blind,comparison of epidural with and without adrenalin. Outcome: Length of birth, quality of pain relief, total amount of epidural solution injected, and plasma concentration of fentanyl.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Pharmacokinetic Interaction Effects of Combined Fentanyl and Adrenalin in Epidural Analgesia During Child Birth
Study Start Date :
Aug 1, 2008
Actual Primary Completion Date :
Jan 1, 2016
Actual Study Completion Date :
Jan 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

adrenalin

Drug: adrenalin
adrenalin 2 microgram pr ml placebo

Placebo Comparator: 2

placebo

Drug: placebo
Saline instead of adrenaline in the epidural mixture

Outcome Measures

Primary Outcome Measures

  1. Plasma concentration of fentanyl [hours]

Secondary Outcome Measures

  1. length of active labor [hours]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pregnant women at term in active labor
Exclusion Criteria:
  • age below 18 years

  • BMI > 40

  • drug hypersensitivity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Akershus University Hospital Lørenskog Norway
2 Division of Anaesthesiology and Intensive Care Medicine, Rikshospitalet University Hospital Oslo Norway 0027

Sponsors and Collaborators

  • Oslo University Hospital
  • University Hospital, Akershus

Investigators

  • Study Director: Vegard Dahl, PhD MD, Dep of Anesethesiology, Akershus University Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Leiv Arne Rosseland, Professor, Oslo University Hospital
ClinicalTrials.gov Identifier:
NCT00685672
Other Study ID Numbers:
  • edaadr-07
  • EUDRACT 2007-000322-52
First Posted:
May 28, 2008
Last Update Posted:
Mar 30, 2016
Last Verified:
Mar 1, 2016
Keywords provided by Leiv Arne Rosseland, Professor, Oslo University Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 30, 2016